It's Thursday morning, 11:50 a.m. ET -- and Eli Lilly (NYSE: LLY) stock is off to the races! This morning, the ...

Also Read: Viking Therapeutics ... respectively. Price Action: LLY stock is up 1.14% at $739.26, NVO stock is up 1.68% at $65.82, ALT stock is up 3.40% at $4.56, VKTX stock is up 13.5% at $ ...

Viking Therapeutics has multiple promising drugs in its portfolio that could generate billions in future revenue. Approval of VK2735 and VK2809 could lead to a surge in the stock's value.

Viking soared more than 100% in one trading session last year on positive clinical trial news. The stock has since given up those gains, but its weight loss drug program continues to advance and ...

Viking Therapeutics (NASDAQ: VKTX) is a promising growth stock with a strong GLP-1 drug candidate in VK2735, which may eventually rake in significant revenue from the anti-obesity market.

Learn More » As for stock performance, Viking won there too in the early part of last year. The stock surged 121% in one trading session about a year ago, right after Viking announced positive ...

The original Jack of all trades, the German Shepherd is adept at all manner of jobs. Bred using traditional German herding ...

Here's what investors should know before adding either one to their portfolios. Viking Therapeutics shares rocketed to an all-time high last February after the company announced positive clinical ...